Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Nindl, Ingo ^a   Dang, Chantip ^a   Forschner, Tobias ^a   Kuban, Ralf J ^a   Meyer, Thomas ^b   Sterry, Wolfram ^a   Stockfleth, Eggert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; DIPEPTIDYL PEPTIDASE I; DNA BINDING PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HISTONE H2A; HLA B ANTIGEN; HLA B39 ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4 RECEPTOR; INTERSTITIAL COLLAGENASE; KARYOPHERIN BETA; KERATIN; LAMIN A; LAMIN C; LECTIN; LECTIN I; LIPOCORTIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; RAB PROTEIN; RAB22B PROTEIN; RAB31 PROTEIN; RNA; S6 KINASE; TENASCIN; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT RECIPIENT; HUMAN; IMMUNE DEFICIENCY; INVASIVE CARCINOMA; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PREDICTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SEQUENCE ANALYSIS; SKIN BIOPSY; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE; UPREGULATION;

ADOLESCENT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 33748876374     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-30     Document Type: Article

References (50)

1. Gloster HM Jr, Brodland DG: The epidemiology of skin cancer. Dermatol Surg 1996, 22:217-226.
2. Marks R, Rennie G, Selwood TS: Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988, 1:795-797.
3. Cockerell CJ: Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000, 42:11-17.
4. Fu W, Cockerell CJ: The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol 2003, 139:66-70.
5. Armstrong BK, Kricker A: The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001, 63:8-18.
6. Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 2001, 344:975-983.
7. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW. Gene expression profiles in normal and cancer cells. Science 1997, 276:1268-1272.
8. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, et al.: Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 2000, 60:2232-2238.
9. Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM, Coman W, Dicker AJ, Saunders NA: Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res 2002, 62:3759-3765.
10. Dazard JE, Gal H, Amariglio N, Rechavi G, Domany E, Givol D: Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 2003, 22:2993-3006.
11. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, Levine AJ: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 1999, 96:6745-6750.
12. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287.
13. Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD: Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res 2000, 60:6744-6749.
14. Dooley TP, Reddy SP, Wilborn TW, Davis RL: Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun 2003, 306:1026-1036.
15. Perou CM, Jeffrey SS, Van de RM, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, et al.: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999, 96:9212-9217.
16. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
17. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben Dor A, et al.: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406:536-540.
18. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, et al.: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143.
19. Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ, Neumann HA: Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Br J Dermatol 2003, 148:102-109.
20. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, Oliveira J, Lopes C, Fliss MS, Sidransky D: Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001, 20:5195-5198.
21. Delsite R, Kachhap S, Anbazhagan R, Gabrielson E, Singh KK: Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer 2002, 1:6.
22. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033.
23. Singh KK: Mitochondrial dysfunction is a common phenotype in aging and cancer. Ann N Y Acad Sci 2004, 1019:260-264.
24. Bryant DM, Stow JL: The ins and outs of E-cadherin trafficking. Trends Cell Biol 2004, 14:427-434.
25. Machida N, Umikawa M, Takei K, Sakima N, Myagmar BE, Taira K, Uezato H, Ogawa Y, Kariya K: Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase. J Biol Chem 2004, 279:15711-15714.
26. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG: Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003, 32:364-371.
27. Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002, 34:204-209.
28. Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, Albert ED, Stolte M, Folwaczny C: Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 2004, 22:4746-4752.
29. Boothby M, Mora AL, Aronica MA, Youn J, Sheller JR, Goenka S, Stephenson L: IL-4 signaling, gene transcription regulation, and the control of effector T cells. Immunol Res 2001, 23:179-191.
30. Bao J, Zervos AS: Isolation and characterization of Nmi, a novel partner of Myc proteins. Oncogene 1996, 12:2171-2176.
31. Zhu M, John S, Berg M, Leonard WJ: Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell 1999, 96:121-130.
32. Li H, Lee TH, Avraham H: A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J Biol Chem 2002, 277:20965-20973.
33. Ong CH, Bateman A: Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol 2003, 18:1275-1288.
34. Chen D, Guo J, Miki T, Tachibana M, Gahl WA: Molecular cloning of two novel rab genes from human melanocytes. Gene 1996, 174:129-134.
35. Bao X, Faris AE, Jang EK, Haslam RJ: Molecular cloning, bacterial expression and properties of Rab31 and Rab32. Eur J Biochem 2002, 269:259-271.
36. Macaluso M, Russo G, Cinti C, Bazan V, Gebbia N, Russo A: Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol 2002, 192:125-130.
37. Mackie EJ: Molecules in focus: tenascin-C. Int J Biochem Cell Biol 1997, 29:1133-1137.
38. Freije JM, Balbin M, Pendas AM, Sanchez LM, Puente XS, Lopez-Otin C: Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 2003, 532:91-107.
39. Bauvois B: Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004, 23:317-329.
40. Tsukifuji R, Tagawa K, Hatamochi A, Shinkai H: Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Br J Cancer 1999, 80:1087-1091.
41. van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken HM, Hoeijmakers JH, Bootsma D: Molecular characterization of the human excision repair gene ERCC-I: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell 1986, 44:913-923.
42. Welsh C, Day R, McGurk C, Masters JR, Wood RD, Koberle B: Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int J Cancer 2004, 110:352-361.
43. Li QQ, Yunmbam MK, Zhong X, Yu JJ, Mimnaugh EG, Neckers L, Reed E: Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. Cell Mol Biol (Noisy-le-grand) 2001 in press.
44. Zhu F, Yan W, Zhao ZL, Chai YB, Lu F, Wang Q, Peng WD, Yang AG, Wang CJ: Improved PCR-based subtractive hybridization strategy for cloning differentially expressed genes. Biotechniques 2000, 29:310-313.
45. Shau H, Butterfield LH, Chiu R, Kim A: Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics 1994, 40:129-134.
46. Lee SC, Na YP, Lee JB: Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells. J Am Acad Dermatol 2003, 49:487-491.
47. Web site of the National Center for Biotechnology Information [http://www.ncbi.nlm.nih.gov/geo]
48. Tibshirani R, Hastie T, Narasimhan B, Chu G: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002, 99:6567-6572.
49. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121.
50. [http://www.broad.mit.edu/cgi-bin/primer/primer3_www.cgi].